Chronic Weight Management
This educational series is proudly made possible by Aspen.
Rethinking obesity – Looking beyond body mass index
by Professor John Wilding
This module explores the health complications associated with obesity, the evolving approach to obesity diagnosis beyond BMI, and current guideline recommendations for comprehensive obesity management. It also highlights the key elements of proactive, person-centred care that extend beyond weight reduction alone.
Obesity is a complex, chronic, progressive and relapsing disease requiring long-term management and treatment
by Professor Barbara McGowan
Diseases are defined by deviations from the normal or healthy structural function of a part, organ or system of the body caused by underlying pathophysiological mechanisms and manifesting with characteristic signs and symptoms.
Trademarks are owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates © 2026 Aspen Group of Companies or its licensor. All rights reserved. For adverse events reporting, contact: ade_za@lilly.com. For product or medical related queries, contact: za_medinfo@lilly.com HCR: Eli Lilly (S.A.) (Pty) Ltd. Reg. No.: 1957/000371. 35 Ballyclare Drive, Bryanston, 2191. Private Bag X119, Bryanston, 2021. Telephone: (011) 510 9300. Pharmacare Limited t/a Aspen Pharmacare. Co. Reg. No. 1898/000252/06 Healthcare Park, Woodlands Drive, Woodmead, 2191.
XX-XX-XX-XXXX XX/XXXX
